| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $400.0M | +29.0% |
| Cost of Revenue | $5.1M | +86.3% |
| R&D Expense | $274.9M | +23.7% |
| SG&A Expense | $165.4M | +6.2% |
| Operating Income | -$45.4M | +35.6% |
| Interest Expense | $12.2M | -35.4% |
| Pre-tax Income | -$19.1M | +63.9% |
| Income Tax | $16.4M | +987.2% |
| Net Income | -$35.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $467.7M | +2.6% |
| Short-term Investments | $396.4M | +8.7% |
| Inventory | $6.7M | +23.8% |
| Current Assets | $996.7M | +7.2% |
| Total Assets | $1.07B | +5.7% |
| Current Liabilities | $246.7M | +16.3% |
| Total Liabilities | $686.2M | +5.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | -141.1% |
| Capital Expenditures | $4.3M | -16.1% |
| Investing Cash Flow | -$16.3M | +95.4% |
| Financing Cash Flow | $12.4M | -96.4% |
| Free Cash Flow | -$15.1M | -172.1% |
| +30.5% |
| EPS (Basic) | -$0.71 | +30.4% |
| EPS (Diluted) | -$0.71 | +30.4% |
| Stockholders' Equity |
| $381.0M |
| +5.6% |